Skip to main content
Bio Solution Co.,Ltd. logo

Bio Solution Co.,Ltd. — Investor Relations & Filings

Ticker · 086820 ISIN · KR7086820008 KO Manufacturing
Open in API
Filings indexed 214 across all filing types
Latest filing 2019-04-24 Regulatory Filings
Country KR South Korea
Listing KO 086820

About Bio Solution Co.,Ltd.

https://bio-solution.co.kr/

Bio Solution Co., Ltd. is a biotechnology company focused on the development, manufacturing, and sale of cell therapy products. The company's core activities involve cell-based biotechnology, producing therapeutics such as autologous chondrocyte treatments for cartilage regeneration. In addition to its therapeutic offerings, Bio Solution develops human tissue models and provides alternative testing solutions. The company also manufactures and distributes a portfolio of bio-laboratory products, including ready-to-use kits, staining solutions, and various reagents for molecular biology research and development applications.

Recent filings

Filing Released Lang Actions
기타경영사항(자율공시)
Regulatory Filings Classification · 1% confidence The document is a regulatory disclosure (자율공시) from BioSolution regarding the approval of a new drug, 'Cartilife', by the Ministry of Food and Drug Safety (MFDS). It is a short, specific announcement of a regulatory event rather than a full financial report or a recurring filing. Since it does not fit into specific categories like M&A, dividends, or share transactions, it falls under the general regulatory filing category.
2019-04-24 Korean
기타경영사항(특허권취득)(자율공시)(구슬형 연골세포 치료제의 제조방법(유럽특허등록))
Regulatory Filings Classification · 1% confidence The document is a regulatory disclosure regarding the acquisition of a patent ('특허권 취득') by BioSolution. It follows the standard format for a voluntary corporate disclosure (자율공시) in the Korean market. Since it does not fit into specific categories like financial reports, M&A, or director dealings, it falls under the general regulatory filing category.
2019-04-17 Korean
기업설명회(IR)개최
Investor Presentation Classification · 1% confidence The document is a short announcement regarding the scheduling of an Investor Relations (IR) meeting. It provides details such as the date, location, target audience, and purpose of the meeting. Since it is an announcement of an upcoming event rather than the presentation materials themselves, and it is under 5,000 characters, it falls under the category of a regulatory filing announcement or general regulatory notice.
2019-04-11 Korean
[기재정정]사업보고서 (2018.12)
Annual Report Classification · 1% confidence The document is a 'Business Report' (사업보고서) for the company 'Biosolution Co., Ltd.' for the fiscal year 2018. It contains comprehensive financial statements, management discussion and analysis, governance information, and auditor opinions. This is the standard Korean regulatory filing equivalent to a 10-K annual report. FY 2018
2019-04-10 Korean
대표이사변경
Board/Management Information Classification · 1% confidence The document is a formal announcement regarding a change in the company's leadership, specifically the appointment of a new co-CEO. It details the 'before' and 'after' status of the representative directors, the reason for the change, the date of the board resolution, and the professional backgrounds of the individuals involved. This aligns perfectly with the definition for Board/Management Information (MANG).
2019-03-29 Korean
본점소재지변경
Regulatory Filings Classification · 1% confidence The document is a short, formal regulatory announcement regarding a change in the company's registered office address (headquarters location). It does not fit into specific categories like financial reports, dividends, or share transactions. As it is a general corporate regulatory disclosure that does not fall into the other specialized categories, it is classified as a Regulatory Filing (RNS).
2019-03-29 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.